menu ☰
menu ˟

CarPac pre-op chemoradiation benefits patients with resectable esophageal cancer

22 Jan 2016
SAN FRANCISCO — After induction therapy, patients with resectable esophageal adenocarcinoma achieved superior pathological complete response with pre-operative carboplatin/paclitaxel based chemoradiation compared with oxaliplatin/capecitabine based...

Click here to view the full article which appeared in

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.